CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE
- PMID: 32061543
- DOI: 10.1016/j.it.2020.01.008
CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE
Abstract
To keep autoreactive T cells under control in SLE patients, immunosuppressive regimens are used, which can increase susceptibility to bacterial and viral infections. Recently, Katsuyama et al., demonstrated that the CD38/NAD/Sirtuin1/EZH2 axis reduces cytolytic CD8+ T cell function and might be targeted to overcome incidence of infections.
Keywords: CD38; EZH2; SLE; T cells; methylation.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Comment on
-
The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections.Cell Rep. 2020 Jan 7;30(1):112-123.e4. doi: 10.1016/j.celrep.2019.12.014. Cell Rep. 2020. PMID: 31914379 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials